Drug profile · INN
safinamide mesylate
SAFINAMIDE MESYLATE
safinamide mesylate (SAFINAMIDE MESYLATE) is a monoamine oxidase b inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — safinamide mesylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
safinamide mesylate (SAFINAMIDE MESYLATE) is a monoamine oxidase b inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Monoamine oxidase B inhibitor
Primary target: Amine oxidase [flavin-containing] B
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is safinamide mesylate?
safinamide mesylate (SAFINAMIDE MESYLATE) is a monoamine oxidase b inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for safinamide mesylate?
SAFINAMIDE MESYLATE is a marketed brand name for safinamide mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of safinamide mesylate?
safinamide mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.